Member Info for Ralphiebabe

Physiomics attending next week.

https://www.physiomics.co.uk/oxford-global-immuno-2024/

Pyc announced contract with Sheffield Uni etc in February, BBC announced following.

More than £2.5m will be ploughed into new research into blood cancer in Sheffield, it has been announced.

The University of Sheffield was given the funding to look into dormant cancer cells and develop new treatments for myeloma, a type of blood cancer.

https://x.com/physiomics/status/1780186840005259327?s=61&t=0G9XeE3tHfuoBf1VEsPycQ

My instinct is telling me that they will take back Fernando Ortega (who was their senior PK/PD Modeller for several years ) for this role.

He had involvement with Dr Hitesh Mistry on a number of projects.

I think he left as his potential wasn’t being used as it should, now with this position he could be enticed back.

These are just my way of thinking, as usual I could be entirely wrong.

From their RNS March 2nd 2022.

Physiomics will be supporting Ankyra with modelling and simulation of ANK-101 in immune-oncology settings in support of its early development.

https://www.physiomics.co.uk/contract-award-9/

Pyc reposted this about a licensing deal between Ankyra and Jenga Bioscience with their platform JEN-101 (formerly cANK-101 (PYC helped developed.)).

https://www.linkedin.com/posts/ankyratx_ankyra-therapeutics-and-jenga-biosciences-activity-7178508921270079488-WtE0?utm_source=share&utm_medium=member_desktop

Interesting.

Dose me posted on twitter on 18th March, Pyc retweeted mentioning they still working with Doseme. I’m awaiting outcome of this.

https://x.com/Physiomics/status/1772939227359007009?s=20

https://x.com/Physiomics/status/1772939225266065552?s=20

Looks like not much interest if they have to put a tweet out at 11:45 informing their presence there.

https://x.com/physiomics/status/1767879752117797059?s=61&t=0G9XeE3tHfuoBf1VEsPycQ

If unable to open previous link.

https://www.physiomics.co.uk/about/careers/

Dr Hitesh Mistry is currently named in that position, has he finally parted ways with Physiomics?

Doesn’t seem much confidence with a positive result tomorrow.

Meanwhile, new post being advertised “Principle Consultant”.

https://uk.linkedin.com/jobs/view/principal-consultant-head-of-modelling-at-physiomics-plc-3848190072

Strange, not sure if PYC has did this in the past when Interims posted.

https://x.com/InvestorMeetCo/status/1763589672016449891?s=20

This week we had following low trades.

Mon 61

Tue 31

Wed 33

Thur 33

Fri. 33

Next week maybe RNS for Interims, will this have an effect on SP?

Will there be another RNS?

Posted today. What I posted on 14th Feb.

https://www.linkedin.com/posts/physiomics-plc_national-research-council-of-canada-announces-activity-7166464012954619904-yl-u?utm_source=li_share&utm_content=feedcontent&utm_medium=g_mb_web&utm_campaign=copy

Https://x.com/VOXmarkets/status/1759534676031471775?s=20

Some info on 2 of the women scientists at Physiomics.

https://www.physiomics.co.uk/celebrating-international-day-of-women-and-girls-in-science-with-the-brilliant-women-at-physiomics/

About 3 pm , PYC posted on LinkedIn their collaboration with Beyond Blood therapeutics etc.

https://www.linkedin.com/posts/physiomics-plc_precisionmedicine-neutropenia-cancer-activity-7163553091907219456-kBuW?utm_source=li_share&utm_content=feedcontent&utm_medium=g_mb_web&utm_campaign=copy

About same time, there was mention of funding for Canada-UK Quantum Projects Garner National Research Council Funding.

One of the projects is with Beyond Blood, 9th project down.

Wonder if PYC will be included with this project?

Canada-UK Quantum Projects Garner National Research Council Funding

https://www.miragenews.com/canada-uk-quantum-projects-garner-national-1173886/

Down to 33 now.

Countdown to news?

No mention of Physiomics being involved.

The following article was edited by Hitesh Mistry and reviewed by Christophe Chassagnole.

This article is part of the Research Topic

FDA Project Optimus: Dose Selection in Oncology Drug Development

Pediatric oncology drug development and dosage optimization

https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1235947/full

Following from PYC blog from Jan 12th.

Welcoming 3 new members to the Team!

Dr Lea Sta (applied mathematician) and Dr David Hodson (mathematical biologist) joined our technical team to support delivery of client projects and expand into new scientific areas. Strengthening our Senior Management Team, we welcomed Dr Peter Sargent as Chief Operating Officer to help drive forward the company’s business strategy.

Wonder if mention of “expanding into new scientific areas”.

https://www.physiomics.co.uk/news-update-from-physiomics-december-2023/